Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1239 Results

Title
Intervention Indication Therapeutic Area Year Actions
Trastuzumab deruxtecan for treating previously untreated locally advanced or metastatic non-small cell lung cancer with HER2 mutations Trastuzumab deruxtecan (DS-8201a; Enhertu) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2024 View  |  Download
Trastuzumab deruxtecan for unresectable or metastatic HER2-low (HR+/-) breast cancer – after chemotherapy Trastuzumab deruxtecan (DS-8201a; Enhertu) Breast cancer Breast Cancer 2021 View  |  Download
Trastuzumab deruxtecan neoadjuvant therapy for high-risk HER2-positive early stage breast cancer Trastuzumab deruxtecan (DS-8201a; Enhertu) Breast cancer Breast Cancer 2023 View  |  Download
Trastuzumab duocarmazine for third-line treatment of HER2-positive unresectable metastatic breast cancer Trastuzumab duocarmazine Breast cancer Breast Cancer 2023 View  |  Download
Trastuzumab Emtansine for HER2-positive breast cancer - adjuvant Trastuzumab Emtansine (Kadcyla; T-DM1; PRO132365) Breast cancer Breast Cancer 2018 View  |  Download
Trastuzumab emtansine in combination with pertuzumab for HER2-positive early breast cancer - adjuvant therapy Pertuzumab (Perjeta; R-1273) , Trastuzumab Emtansine (Kadcyla; T-DM1; PRO132365) Breast cancer Breast Cancer 2019 View  |  Download
Treosulfan in combination with Fludarabine for Malignant and Non-Malignant diseases - prior to stem cell transplantation Fludarabine (fludarabine phosphate) , Treosulfan (Ovastat) Acute myeloid leukaemia (AML) , Myelodysplastic syndrome (MDS) Haematological Cancer and Lymphomas 2018 View  |  Download
Treosulfan in combination with fludarabine for paediatric non-malignant disease before allogeneic stem cell transplant Fludarabine (fludarabine phosphate) , Treosulfan (Ovastat) Non-malignant diseases Endocrine Nutritional and Metabolic Disorders , Haematology , Immunology 2019 View  |  Download
Treprostinil diethanolamine for treating pulmonary arterial hypertension Treprostinil diethanolamine Paroxysmal nocturnal haemoglobinuria Cardiovascular System , Respiratory System 2022 View  |  Download
Treprostinil for chronic thromboembolic pulmonary hypertension Hybrid treprostinil (Trepulmix) Chronic thromboembolic pulmonary hypertension (CTEPH) Cardiovascular System 2020 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications